Search

ADJUVANT RADIATION FOR POSITIVE MARGINS IN ADULT H&N SARCOMAS IS ASSOCIATED WITH IMPROVED SURVIVAL: ANALYSIS OF THE NATIONAL CANCER DATABASE

Immunotherapy and Other Adjuvant Treatments

Richard B Cannon, MD, Patrick Carpenter, MD, Amanda J Kull, MD, Sam Francis, MD, Luke O Buchmann, MD, Jason P Hunt, MD, Shane Lloyd, MD, Ying J Hitchcock, MD, John R Weis, MD, Marcus M Monroe, MD

University of Utah

PD-L1 MAY SERVE AS A PROGNOSTIC BIOMARKER IN HPV-ASSOCIATED HEAD AND NECK CANCER PATIENTS

Immunotherapy and Other Adjuvant Treatments

Austin K Mattox¹, Francesco Sabbatino², Vincenzo Villani², Soldano Ferrone², William C Faquin³, Hang Lee⁴, Jill Brooks⁵, Armida Lefranc-Torres⁶, Derrick T Lin⁶, Lori J Wirth⁷, Christopher C McConkey⁸, Hisham Mehanna⁵, Sara I Pai²

¹Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, ²Department of Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ³Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁴Biostatistics Center, Massachusetts General Hospital, Harvard Medical School, Boston, MA, ⁵Institute of Head and Neck Studies and Education (InHANSE), University of Birmingham, UK, ⁶Department of Otology and Laryngology, Massachusetts Eye and Ear Infirmary, Boston, MA, ⁷Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, ⁸Warwick Clinical Trials Unit, University of Warwick, UK

THE ADDITION OF CHEMOTHERAPY TO THE ADJUVANT THERAPY OF LATE-STAGE SALIVARY SQUAMOUS CELL CARCINOMA IS ASSOCIATED WITH IMPROVED PATIENT SURVIVAL

Immunotherapy and Other Adjuvant Treatments

Shayan Cheraghlou, BA, Cheryl K Zogg, MSPH, MHS, Michael D Otremba, MD, Henry S Park, MD, MPH, Aarti Bhatia, MD, MPH, Saral Mehra, MD, MBA, Heather A Osborn, MD, Wendell G Yarbrough, MD, Benjamin L Judson, MD

Yale Medical School

DOES PERIOPERATIVE OXANDROLONE IMPROVE NUTRITIONAL STATUS IN PATIENTS WITH CACHEXIA RELATED TO HEAD AND NECK CARCINOMA?

Immunotherapy and Other Adjuvant Treatments

Angela M Osmolak, MD, Cristine Klatt-Lasso, MD, Amber Price, MD, Jose A Sanclement, MD, Greg A Krempl, MD

University of Oklahoma Health Science Center

LONGITUDINAL IMMUNE COMPLEXITY ANALYSIS USING 29-BIOMARKER MULTIPLEX IMMUNOHISTOCHEMISTRY IN PRIMARY AND RECURRENT HEAD AND NECK SQUAMOUS CELL CARCINOMA

Immunotherapy and Other Adjuvant Treatments

Grace L Banik, MD¹, Rie Kawashima, DDS, PhD², Tiziana Cotechini, PhD², Sara I Pai, MD, PhD³, Armida LeFranc-Torres⁴, Derrick T Lin, MD⁴, Lori J Wirth, MD⁵, Daniel R Clayburgh, MD, PhD⁶, Lisa M Coussens, PhD⁷, Takahiro Tsujikawa, MD, PhD⁸

¹Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University, ²Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University, ³Department of Surgery, Massachusetts General Hospital, Harvard University, ⁴Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, ⁵Department of Medicine, Massachusetts General Hospital, Harvard University, ⁶Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University; Knight Cancer Institute, Oregon Health and Science University, ⁷Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University; Knight Cancer Institute, Oregon Health and Science University, ⁸Department of Otolaryngology-Head and Neck Surgery, Oregon Health and Science University; Department of Cell, Developmental and Cancer Biology, Oregon Health and Science University; Knight Cancer Institute, Oregon Health and Science University; Department of Otolaryngology, Head and Neck Surgery, Kyoto Prefectural University of Medicine